Though it beat FQ3 estimates, Synopsys (NASDAQ:SNPS) is guiding for FQ4 revenue of $537M-$547M and EPS of $0.59-$0.61, mostly below a consensus of $547M and $0.63.
FQ3 time-based license revenue +11% Y/Y to $431.2M; up-front license revenue -21% to $31.6M; maintenance/service revenue +6% to $59M. GAAP R&D spend +10% to $182.8M; sales/marketing +7% to $112.3M.
Synopsys says it's seeing "encouraging results" from recently-acquired software quality/testing tool vendor Coverity.
Shares -0.8% AH. FQ3 results, PR.